Russian Federation
Russian Federation
Russian Federation
Russian Federation
The article presents review and a clinical case of the pulmonary Langerhans cell histiocytosis which can occure in the practice of a general practitioner.
pulmonary Langerhans cell histiocytosis, histiocytosis X, interstitial lung injury, smoking
1. Karamova A.E., Chikin V.V., Znamenskaya L.F. i dr. Gistiocitoz iz kletok Langergansa u vzrosloy pacientki // Vestnik dermatologii i venerologii. – 2019 – № 95(4). – S. 57–66. Doi:https://doi.org/10.25208/0042-4609-2019-95-4-57-66
2. Gorlanov I.A., Zaslavskiy D.V., Mineeva O.K. i dr. Gistiocitoz iz kletok Langergansa (gistiocitoz H): klinicheskoe nablyudenie // Vestnik dermatologii i venerologii. – 2013 – № 1 – S. 51–55.
3. Burcev E.A., Bronin G.O. Gistiocitoz iz kletok Langergansa u detey: obzor literatury // Voprosy sovremennoy pediatrii. – 2023 – № 22(1). – S. 13–22. https://doi.org/10.15690/vsp.v22i1.2520
4. Potapenko V.G., Baykov V.V., Zinchenko i dr. Gistiocitoz iz kletok Langergansa u vzroslyh: obzor literatury // Onkogematologiya. – 2022 – № 17(4). – S. 16–32. Doi:https://doi.org/10.17650/1818-8346-2022- 17-4-16-32
5. Liu H., Osterburg A.R., Flury J. et al. MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis // JCI Insight. – 2020 – T 5 − № 4 Doi:https://doi.org/10.1172/jci.insight.132048
6. Sawalha L., Kumar A., Arshad A. et al. Pulmonary Langerhans cell histiocytosis: radiologic resolution following cessation of second hand smoking // Clin Respir J. – 2017 – T. 11 – № 6 – P. 1063–1067. Doi: 10.1111/ crj.12445
7. Shumilin A.A., Pavlov A.I., Prohorchik A.A. i dr. Redkie formy intersticial'nyh bolezney legkih. Klinicheskiy sluchay legochnogo gistiocitoza H // Effektivnaya farmakoterapiya. – 2023 – № 19 (20). – S. 26–31. Doihttps://doi.org/10.33978/2307-3586-2023-19-20-26-31
8. Reisi N., Raeissi P., Khalilabad T. et al. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature // Orphanet J Rare Dis. − 2021 – T. 16 – N . 1 Doi :https://doi.org/10.1186/s13023-020-01625-z
9. Latyshev V.D., Lukina E.A. Gistiocitoz iz kletok Langergansa u vzroslyh: sovremennye vozmozhnosti terapii // Klinicheskaya onkogematologiya. – 2021 – № 14(4). – S. 444–454. Doi:https://doi.org/10.21320/2500-2139-2021-14-4-444-454
10. Varghese J., Muntode Gharde P. A Comprehensive Review on the Impacts of Smoking on the Health of an Individual // Cureus. – 2023 – T. 15 – N 10 Doi:https://doi.org/10.7759/cureus.46532
11. Novosad O., Skrypets T., Pastushenko Y. et al. MAPK/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis // Klin Onkol. – 2018 Spring. – T. 31 – N 2 – R. 130–136. Doi:https://doi.org/10.14735/amko2018130
12. Gur'eva O.D., Valiev T.T., Pavlovskaya A.I. Gistiocitarnye opuholi: sovremennye aspekty patogeneza, klassifikacii, diagnostiki i lecheniya // Onkogematologiya. – 2022 – № 17(1). – S. 10– 25 Doi:https://doi.org/10.17650/1818-8346-Sh 2022-17-1-10-25
13. Grobost V., Khouatra C., Lazor R. et al. Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis // Orphanet J Rare Dis. – 2014 – N 9 Doi:https://doi.org/10.1186/s13023-014-0191-8
14. Nasser M., Traclet J., Cottin V. Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis // ERJ Open Res. – 2018 – № 4(1). Doi:https://doi.org/10.1183/23120541.00089-2017
15. Tazi A., de Margerie C., Naccache J.M. et al. The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study // Orphanet J Rare Dis. – 2015 – N 30 Doi:https://doi.org/10.1186/s13023-015-0249-2
16. Vassallo R., Harari S., Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis // Thorax. – 2017 – N 72 (10). – R. 937–945. Doi:https://doi.org/10.1136/thoraxjnl-2017-210125
17. Lorillon G., Tazi A. How I manage pulmonary Langerhans cell histiocytosis // Eur Respir Rev. – 2017 – N 26 (145). Doi:https://doi.org/10.1183/16000617.0070-2017
